Improved survival for patients with lung cancer treated with perioperative immunotherapy

Lancet. 2024 Sep 28;404(10459):1176-1178. doi: 10.1016/S0140-6736(24)01920-2. Epub 2024 Sep 14.

Authors

Carolyn J Presley¹, Dwight H Owen²

Affiliations

¹ The Ohio State University Comprehensive Cancer Center/The James Cancer Hospital & Solove Research Institute, Columbus, OH 43210, USA. Electronic address: carolyn.presley@osumc.edu.
² The Ohio State University Comprehensive Cancer Center/The James Cancer Hospital & Solove Research Institute, Columbus, OH 43210, USA.

PMID: 39288778
DOI: 10.1016/S0140-6736(24)01920-2

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung / mortality
Carcinoma, Non-Small-Cell Lung / therapy
Humans
Immunotherapy* / methods
Lung Neoplasms* / mortality
Lung Neoplasms* / therapy
Perioperative Care / methods